Malvern Treatment Centers

Stay Connected With Malvern. Get Email Updates

info@malverninstitute.com | Follow Us:

FDA encourages new medications for opioid addiction

March 1, 2018 – Removing barriers so individuals struggling with the disease of addiction can access treatment should be a goal for policymakers. Identifying effective and evidence-based methods for treatment – like Malvern Treatment Centers utilizes – will assist individuals to begin the recovery process.

The U.S. Food and Drug Administration is expected to bolster medication-assisted treatment options through new guidelines, according to WHYY. These medications could ease withdrawal symptoms and cravings for individuals struggling with addiction:

The new FDA guidelines are part of its strategy for promoting drugs that can ease withdrawal symptoms and cravings for people addicted to opioids.

The guidelines would make it easier to get new medications approved that are shown to help in some way with a patient’s recovery, even if the person doesn’t stop using drugs completely.

“This is moving us in the right direction, but there are a slew of effective drugs that are already out there,” said Dr. Geoffrey Neimark, the chief medical officer for Community Behavioral Health, which runs Philadelphia’s network of addiction treatment providers for people on Medicaid.

Malvern Treatment Centers: We Give Hope

If you or a loved one are living with addiction, we can help. Learn about Malvern Intervention Services or the Malvern Model Of Care by calling 610.MALVERN (610.625.8376).

Read the full story from WHYY.

Testimonials

Recent News

Dr. Peter Swanljung Appointed to Chief Medical Officer

Malvern Health is proud to announce that Dr. Peter Swanljung has been appointed as our new Chief Medical Officer.  Dr. Swanljung will be responsible for the physician and medical oversight of all of our bed-based services including our two Malvern Treatments Centers addiction facilities and our new...

Read More

See All News

© 2020 Malvern Treatment Centers - All Rights Reserved | View Privacy Policy